| Metastasis and carcinoma case studies | Lifetime | 3 | JP 1 | 99.84 |
| Gastric Cancer Management and Outcomes | Lifetime | 20 | JP 2 | 99.89 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 36 | JP 5 | 99.72 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 33 | JP 6 | 99.68 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 247 | JP 6 | 99.25 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 153 | JP 13 | 99.39 |
| Colorectal Cancer Treatments and Studies | Lifetime | 143 | JP 10 | 99.49 |
| Esophageal Cancer Research and Treatment | Lifetime | 107 | JP 15 | 99.23 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 156 | JP 22 | 99.35 |
| Lung Cancer Treatments and Mutations | Lifetime | 270 | JP 20 | 99.29 |
| Cancer Research and Treatments | Lifetime | 177 | JP 7 | 98.73 |
| Genetic factors in colorectal cancer | Lifetime | 199 | JP 6 | 99.08 |
| Liver Disease Diagnosis and Treatment | Lifetime | 597 | JP 43 | 99.22 |
| Liver Disease and Transplantation | Lifetime | 236 | JP 13 | 99.29 |
| Colorectal and Anal Carcinomas | Lifetime | 142 | JP 8 | 98.81 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 417 | JP 11 | 99.03 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 450 | JP 53 | 98.86 |
| Multiple and Secondary Primary Cancers | Lifetime | 116 | JP 1 | 98.47 |
| RNA modifications and cancer | Lifetime | 806 | JP 44 | 98.48 |
| Cancer, Lipids, and Metabolism | Lifetime | 415 | JP 12 | 98.40 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 528 | JP 56 | 98.61 |
| Peptidase Inhibition and Analysis | Lifetime | 648 | JP 26 | 97.84 |
| Cancer-related Molecular Pathways | Lifetime | 584 | JP 22 | 98.01 |
| Cancer Cells and Metastasis | Lifetime | 602 | JP 26 | 97.56 |
| Cancer-related gene regulation | Lifetime | 530 | JP 53 | 97.47 |
| Cancer Diagnosis and Treatment | Lifetime | 571 | JP 18 | 97.23 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 200 | JP 36 | 95.50 |
| Cancer therapeutics and mechanisms | Lifetime | 475 | JP 36 | 97.53 |
| Angiogenesis and VEGF in Cancer | Lifetime | 418 | JP 22 | 97.43 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 698 | JP 81 | 97.74 |
| Cancer Treatment and Pharmacology | Lifetime | 867 | JP 26 | 97.72 |
| Esophageal and GI Pathology | Lifetime | 851 | JP 84 | 97.39 |
| Lung Cancer Research Studies | Lifetime | 671 | JP 52 | 97.74 |
| Organ Donation and Transplantation | Lifetime | 582 | JP 22 | 96.09 |
| Cancer Mechanisms and Therapy | Lifetime | 557 | JP 39 | 94.77 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 738 | JP 29 | 94.67 |
| Liver physiology and pathology | Lifetime | 899 | JP 150 | 94.08 |
| Abdominal vascular conditions and treatments | Lifetime | 441 | JP 27 | 92.77 |
| Cardiac tumors and thrombi | Lifetime | 992 | JP 58 | 92.53 |
| Liver Diseases and Immunity | Lifetime | 1,000 | JP 93 | 93.07 |
| Lymphatic System and Diseases | Lifetime | 967 | JP 83 | 85.93 |
| Lymphatic Disorders and Treatments | Lifetime | 454 | JP 44 | 69.07 |